Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Self-reported alcohol use in the cystic fibrosis community.

Lowery EM, Afshar M, West N, Kovacs EJ, Smith B, Joyce C.

J Cyst Fibros. 2019 Jul 11. pii: S1569-1993(19)30805-7. doi: 10.1016/j.jcf.2019.06.004. [Epub ahead of print]

PMID:
31303381
2.

Association between diverticular disease requiring surgical intervention and mortality in the postlung transplant population - a retrospective cohort study.

Tague LK, Adams W, Young KA, Kwon OJ, Mahoney E, Lowery EM.

Transpl Int. 2019 Jul;32(7):739-750. doi: 10.1111/tri.13417. Epub 2019 Mar 25.

PMID:
30793380
3.

Lung allograft donors with excessive alcohol use have increased levels of human antimicrobial peptide LL-37.

Camargo Moreno M, Lewis JB, Kovacs EJ, Lowery EM.

Alcohol. 2019 Nov;80:109-117. doi: 10.1016/j.alcohol.2018.11.003. Epub 2018 Nov 9.

PMID:
30419299
4.

Use of alcohol biomarkers to identify alcohol misuse in organ donors.

Lowery EM, Walsh M, Yong M, Kovacs EJ, Joyce C, Afshar M.

Alcohol. 2018 Dec;73:67-72. doi: 10.1016/j.alcohol.2018.03.010. Epub 2018 Mar 31.

5.

Optimal Cut-Points for Phosphatidylethanol Vary by Clinical Setting: Response to Nguyen and Seth's (2018) Letter to the Editor.

Afshar M, Burnham EL, Joyce C, Kovacs EJ, Lowery EM.

Alcohol Clin Exp Res. 2018 Oct;42(10):2064-2065. doi: 10.1111/acer.13853. Epub 2018 Aug 13. No abstract available.

6.

Recent alcohol use prolongs hospital length of stay following lung transplant.

Lowery EM, Yong M, Cohen A, Joyce C, Kovacs EJ.

Clin Transplant. 2018 Jun;32(6):e13250. doi: 10.1111/ctr.13250. Epub 2018 Jun 20.

7.

Cut-Point Levels of Phosphatidylethanol to Identify Alcohol Misuse in a Mixed Cohort Including Critically Ill Patients.

Afshar M, Burnham EL, Joyce C, Clark BJ, Yong M, Gaydos J, Cooper RS, Smith GS, Kovacs EJ, Lowery EM.

Alcohol Clin Exp Res. 2017 Oct;41(10):1745-1753. doi: 10.1111/acer.13471. Epub 2017 Sep 13.

8.

Increased risk of PTLD in lung transplant recipients with cystic fibrosis.

Lowery EM, Adams W, Grim SA, Clark NM, Edwards L, Layden JE.

J Cyst Fibros. 2017 Nov;16(6):727-734. doi: 10.1016/j.jcf.2017.03.013. Epub 2017 Apr 27.

9.

Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.

Bharat A, Cunningham SA, Scott Budinger GR, Kreisel D, DeWet CJ, Gelman AE, Waites K, Crabb D, Xiao L, Bhorade S, Ambalavanan N, Dilling DF, Lowery EM, Astor T, Hachem R, Krupnick AS, DeCamp MM, Ison MG, Patel R.

Sci Transl Med. 2015 Apr 22;7(284):284re3. doi: 10.1126/scitranslmed.aaa8419.

10.

Heavy alcohol use in lung donors increases the risk for primary graft dysfunction.

Lowery EM, Kuhlmann EA, Mahoney EL, Dilling DF, Kliethermes SA, Kovacs EJ.

Alcohol Clin Exp Res. 2014 Nov;38(11):2853-61. doi: 10.1111/acer.12553.

11.

The aging lung.

Lowery EM, Brubaker AL, Kuhlmann E, Kovacs EJ.

Clin Interv Aging. 2013;8:1489-96. doi: 10.2147/CIA.S51152. Epub 2013 Nov 6. Review.

12.

Low vitamin D levels are associated with increased rejection and infections after lung transplantation.

Lowery EM, Bemiss B, Cascino T, Durazo-Arvizu RA, Forsythe SM, Alex C, Laghi F, Love RB, Camacho P.

J Heart Lung Transplant. 2012 Jul;31(7):700-7. doi: 10.1016/j.healun.2012.02.012. Epub 2012 Mar 3.

PMID:
22386448
13.

Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis.

Henrich CJ, Thomas CL, Brooks AD, Booth NL, Lowery EM, Pompei RJ, McMahon JB, Sayers TJ.

Apoptosis. 2012 Jan;17(1):79-89. doi: 10.1007/s10495-011-0652-7.

Supplemental Content

Loading ...
Support Center